Results 261 to 270 of about 4,627,885 (297)

PROTEIN KINASE INHIBITORS

2009
BA-MAUNG NWE Y, BELL RANDY L, CLARK RICHARD F, ERICKSON SCOTT A, FIDANZE STEVE D, HUBBARD ROBERT D, MANTEI ROBERT A, SHEPPARD GEORGE S, SORENSEN BRYAN K, WANG GARY T, WANG JIEYI   +10 more
openaire   +2 more sources

Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks

Journal of Medicinal Chemistry, 2012
Tjeerd Barf
exaly  

The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity

FEBS Letters, 1999
Jeremy M Tavaré, Ingeborg Hers, Richard M Denton   +2 more
exaly  

PROTEIN KINASE INHIBITORS

2003
BURNS CHRISTOPHER JOHN, BU XIANYONG, WILKS ANDREW FREDERICK   +2 more
openaire   +3 more sources

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Pharmacology & Therapeutics, 1999
Pascal Furet, Peter Traxler, P Traxler
exaly  

Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

Bioorganic and Medicinal Chemistry Letters, 2005
Len Lee, David R Anderson
exaly  

Inhibitors of Protein Kinases

2009
ALLGEIER HANS, AUGUSTIN MARTIN, MUELLER ANKE, ZEITLMANN LUTZ, MARQUARDT ANDREAS, PLEISS MICHAEL A, HEISER ULRICH, NIESTROJ ANDRE JOHANNES   +7 more
openaire   +3 more sources

A comprehensive review of protein kinase inhibitors for cancer therapy

Expert Review of Anticancer Therapy, 2018
Daruka Mahadevan
exaly  

Protein kinase inhibitors

2013
LINNANEN TERO, WOHLFAHRT GERD, NANDURI SRINIVAS, UJJINAMATADA RAVI, RAJAGOPALAN SRINIVASAN, MUKHERJEE SUBHENDU   +5 more
openaire   +5 more sources

A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Talia Golan, Jennifer K Litton, Nicolas Sayegh   +2 more
exaly